1. Home
  2. |Insights
  3. |Global Competition Review Once Again Recognizes Crowell & Moring’s Antitrust & Competition Group in "GCR 100"

Global Competition Review Once Again Recognizes Crowell & Moring’s Antitrust & Competition Group in "GCR 100"

Firm News | 2 min read | 12.16.21

Washington – December 15, 2021: Global Competition Review once again recognized Crowell & Moring’s Antitrust & Competition Group in its annual “GCR 100” – the leading ranking of the world’s competition policy law and economics practices. This year marks the 22nd edition of the awards and the 15th consecutive year that the Antitrust & Competition Group has been recognized.

In New York, the firm received a ranking of “Highly Recommended,” with the leadership of Olivier Antoine and Juan Arteaga noted. GCR recognized Antoine for his work in representing AT&T in connection with both the divestiture of its Warner Media business to Discovery and the sale of a significant interest in DirecTV TPG Capital.  GCR also recognized Arteaga for his work in representing CSX Transportation.

In Washington, GCR spotlighted multiple efforts, including Alexis Gilman’s work securing approval from the Federal Trade Commission and North Carolina attorney general for Novant Health’s acquisition of New Hanover Regional Medical Center without a full-phase investigation or remedy. Antitrust & Competition Group co-chair Shawn Johnson was recognized for his work representing AT&T in connection with the sale of its streaming anime business, Crunchyroll, to Sony Funimation, a merger that closed without conditions after an in-depth investigation by the Antitrust Division of the Department of Justice.

Antitrust & Competition Group co-chair Jason Murray’s leadership in California was spotlighted by the publication, including his efforts helping the City of Los Angeles Harbor Department “defeat allegations it illegally restrained competition” at North America’s largest port. Partner Jordan Ludwig and counsel Katie Yablonka were also highlighted for their representation of Cardinal Health in a drug pricing case.

In Belgium, the publication highlighted the arrival of Karel Bourgeois to the firm in January 2021, as well as the firm’s advising of the IPM Group “on its acquisition of the newspapers L’Avenir and Journal des Enfants, and the magazines Moustique and Télé Pocket,” which cleared Belgian authorities unconditionally.

To read the firm’s full listing in the “GCR 100,” visit here.

About Crowell & Moring LLP

Crowell & Moring LLP is an international law firm with offices in the United States, Europe, MENA, and Asia that represents clients in litigation and arbitration, regulatory and policy, and transactional and corporate matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation and government-facing matters, as well as its ongoing commitment to pro bono service and diversity, equity, and inclusion.

Insights

Firm News | 1 min read | 03.11.25

Crowell & Moring Represents Nuclear Energy Startup Atomic Alchemy in its Acquisition by Oklo

March 11, 2025: Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced on March 5, 2025 that it has closed the $25 million acquisition of Crowell client Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Oklo intends to use this strategic acquisition to establish a more reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Demand for radioisotopes is expected to increase significantly over the next decade, while global supply struggles to keep pace due to aging reactor infrastructure and a fragmented global supply chain, which at present is dominated by countries outside the United States. Atomic Alchemy intends to be a low-cost U.S. radioisotope producer that can provide a secure and domestic supply of radioisotopes to U.S. companies commercializing innovative radioisotope applications. With its proprietary VIPR® technology, Atomic Alchemy is building the first scalable production facility to provide a reliable, sustainable source of high-value radioisotopes. Using a vertically integrated model and fuel recycling, in partnership with Oklo, Atomic Alchemy is transforming isotope production to address global shortages, support critical applications, and strengthen national security. The core deal team included Samuel Holland Edwards, Jon O’Connell, Justin Lurie, and Ryan Flynn....

View All Insights